Know Cancer

or
forgot password

Prognostic and Therapeutic Relevance of the 'Side Population' in Pancreatic Cancer


N/A
18 Years
85 Years
Not Enrolling
Both
Neoplasm, Pancreas

Thank you

Trial Information

Prognostic and Therapeutic Relevance of the 'Side Population' in Pancreatic Cancer


Inclusion Criteria:



- Resected pancreatic ductal adenocarcinoma (PDAC)

- Informed consent

Exclusion Criteria:

- Age < 18years

- Pregnancy

- Pre-operative radiotherapy

- Pre-operative chemotherapy

- IPMT

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Characterization of side population (SP) cells in pancreatic ductal adenocarcinoma (PDAC)

Safety Issue:

No

Authority:

Belgium: Institutional Review Board

Study ID:

BT-PDAC-SP

NCT ID:

NCT00936104

Start Date:

August 2008

Completion Date:

July 2012

Related Keywords:

  • Neoplasm
  • Pancreas
  • pancreas
  • cancer
  • stem cell
  • Neoplasms
  • Carcinoma, Ductal, Breast

Name

Location